𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis

✍ Scribed by Maria do Carmo Filomena Mesquita; Eugénie Bakoto Sol; Marianne Malarme; Denis Noubouossie; Anne Claire Demulder

Book ID
113544080
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
113 KB
Volume
31
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful treatment of essential thromb
Successful treatment of essential thrombocythemia with anagrelide in a child
✍ Hermann, Johann; Fuchs, Dietlinde; Sauerbrey, Axel; Hempel, Lutz; Zintl, Felix 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

The patient to be discussed today is an 8 1 ⁄2-year-old girl. She was referred to us in February 1994 when 4 years old because of recurrent severe headaches, paraesthesias of the extremities, erythromelalgia, abdominal pain, and a platelet count of between 1,300 and 1,500 × 10 9 /L. Physical examina

PDGF-A, PDGF-B, TGFβ, and bFGF mRNA leve
PDGF-A, PDGF-B, TGFβ, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide
✍ Paola R. Lev; Juan P. Salim; Laura I. Kornblihtt; Carlos J. Pirola; Rosana F. Ma 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

Plasmatic levels of PDGF-AB, TGFb 1 , and bFGF are increased in patients with essential thrombocythemia (ET) while intraplatelet levels are low for PDGF, normal for TGFb, and elevated for bFGF. To evaluate the contribution of gene expression to the dysregulated cytokine levels, we studied platelet P